Literature DB >> 1930775

Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack).

M A Chiasson1, R L Stoneburner, D S Hildebrandt, W E Ewing, E E Telzak, H W Jaffe.   

Abstract

A study of risk factors for HIV-1 infection was conducted at a sexually transmitted disease clinic in an area of New York City where the cumulative incidence of AIDS in adults through mid-1990 was 9.1 per 1000 of the population and where the use of illicit drugs, including smokable freebase cocaine (crack), is common. The overall seroprevalence among volunteers was 12% (369 out of 3084), with 80% of those who were seropositive reporting risk behavior associated with HIV-1 infection, including male-to-male sexual contact, intravenous drug use and heterosexual contact with an intravenous drug user. The seroprevalence in individuals denying these risks was 3.6% (50 out of 1389) and 4.2% (22 out of 522) in men and women, respectively. Among these individuals, the behaviors significantly associated with infection were use of crack and prostitution in women, and history of syphilis and crack use in men. These results suggest that in areas where the level of HIV-1 infection in heterosexual intravenous drug users is high and the use of crack is common, increased sexual activity (including the exchange of drugs or money for sex) may result in increased heterosexual transmission of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930775     DOI: 10.1097/00002030-199109000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  42 in total

Review 1.  Immunological functions of the human prepuce.

Authors:  P M Fleiss; F M Hodges; R S Van Howe
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

Review 2.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

3.  HIV seroprevalence among homeless and marginally housed adults in San Francisco.

Authors:  Marjorie J Robertson; Richard A Clark; Edwin D Charlebois; Jacqueline Tulsky; Heather L Long; David R Bangsberg; Andrew R Moss
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

4.  Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.

Authors:  Tanya Telfair Sharpe; Lisa M Lee; Allyn K Nakashima; Laurie D Elam-Evans; Patricia L Fleming
Journal:  J Community Health       Date:  2004-04

Review 5.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

Review 6.  Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Blaise Mathias-Costa; Vijeta Singh; Pankaj Seth; John Wang; Tsung-Ping Su
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 7.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

8.  HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities.

Authors:  A H Kral; R N Bluthenthal; R E Booth; J K Watters
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

9.  The changing landscape of crack cocaine use and HIV infection.

Authors:  David Celentano; Susan G Sherman
Journal:  CMAJ       Date:  2009-10-19       Impact factor: 8.262

10.  A comparison of the social and sexual networks of crack-using and non-crack using African American men who have sex with men.

Authors:  Karin Elizabeth Tobin; Danielle German; Pilgrim Spikes; Jocelyn Patterson; Carl Latkin
Journal:  J Urban Health       Date:  2011-12       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.